Objective There are currently no targeted therapies against lung tumors with oncogenic K-ras mutations that are found in 25% to ?40% of lung cancers and are characterized by their resistance to epidermal growth factor receptor inhibitors. 106 cells per well in 12-well plates in full media for 24 hours and then serum-starved BMS-345541 HCl them… Continue reading Objective There are currently no targeted therapies against lung tumors with